There have been some possible problems reported recently with sulfur colloid, which is, by the way, not approved by the F. D. A. as currently used in locating sentinel lymph nodes. My semi-educated guess is that no hard sell will be necessary, for all the obvious reasons stemming from the above facts. (Sulfur colloid is not exactly given away, either.)
That being said, I'll let everyone do his own research on the subject and remind all that Lymphoseek is not yet approved and that Neoprobe is therefore subject to all the usual risks which that circumstance entails. I only intended my message as a heads up for any (like you) who might be casually watching the stock. I'm sure all the holders have already digested this new news release.